Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 15.55
+0.70 (4.71%)
Jan 22, 2026, 1:53 PM CST
Vectorite Biomedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -23.19 | -40.05 | -6.6 | -26.41 | 8.36 | -68.17 | Upgrade |
Depreciation & Amortization | 8.57 | 8.76 | 9.16 | 8.86 | 16.49 | 19.12 | Upgrade |
Other Amortization | - | - | - | - | 0.02 | 0.22 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | - | - | - | - | -1 | Upgrade |
Asset Writedown & Restructuring Costs | 16.02 | 15.77 | 0.73 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -5.43 | 6.4 | -3.88 | 0.98 | -51.05 | - | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | 5.84 | 14.96 | Upgrade |
Stock-Based Compensation | - | - | - | - | - | 0.54 | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | - | 0.02 | - | Upgrade |
Other Operating Activities | -0.03 | -0.02 | -0.03 | -0.04 | -0.02 | -3.47 | Upgrade |
Change in Accounts Receivable | -5.29 | -0.47 | -0.05 | -4.48 | 1.17 | -0.52 | Upgrade |
Change in Inventory | -2.81 | -4.75 | -5.21 | 2.41 | -1.92 | 1.53 | Upgrade |
Change in Accounts Payable | -0.89 | -0.06 | -1.98 | 0.47 | 1.06 | -1.46 | Upgrade |
Change in Unearned Revenue | 1.85 | 1.83 | -2.53 | -0.81 | 2.66 | -0.76 | Upgrade |
Change in Other Net Operating Assets | 1.94 | 1.1 | 5.62 | -6.42 | -2.82 | 2.11 | Upgrade |
Operating Cash Flow | -9.29 | -11.51 | 1.3 | 14.7 | -65.79 | -36.9 | Upgrade |
Operating Cash Flow Growth | - | - | -91.17% | - | - | - | Upgrade |
Capital Expenditures | -0.86 | -2.84 | -4.76 | -0.89 | -1.8 | -0.77 | Upgrade |
Sale of Property, Plant & Equipment | 0.04 | - | - | - | - | 1.65 | Upgrade |
Divestitures | - | - | - | - | - | -86.14 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | - | -10.34 | Upgrade |
Investment in Securities | 15.69 | 24.08 | 1.33 | -25.2 | -39.88 | -68.76 | Upgrade |
Other Investing Activities | -5.9 | -4.87 | -0.4 | -0.25 | 0.01 | 0.82 | Upgrade |
Investing Cash Flow | 8.96 | 16.36 | -3.82 | -26.34 | -41.67 | -163.54 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 50 | Upgrade |
Total Debt Issued | - | - | - | - | - | 50 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -65 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -0.96 | Upgrade |
Total Debt Repaid | -0.06 | - | - | - | - | -65.96 | Upgrade |
Net Debt Issued (Repaid) | -0.06 | - | - | - | - | -15.96 | Upgrade |
Issuance of Common Stock | - | - | - | - | 118.08 | 130.17 | Upgrade |
Other Financing Activities | -0.2 | 0.2 | - | - | - | 0.01 | Upgrade |
Financing Cash Flow | -0.26 | 0.2 | - | - | 118.08 | 114.22 | Upgrade |
Foreign Exchange Rate Adjustments | -0.29 | 0.23 | -0.04 | 0.32 | -0.18 | -0.35 | Upgrade |
Net Cash Flow | -0.88 | 5.29 | -2.56 | -11.32 | 10.44 | -86.57 | Upgrade |
Free Cash Flow | -10.15 | -14.35 | -3.46 | 13.81 | -67.59 | -37.67 | Upgrade |
Free Cash Flow Margin | -14.95% | -24.84% | -6.19% | 32.19% | -234.93% | -153.49% | Upgrade |
Free Cash Flow Per Share | -0.23 | -0.33 | -0.08 | 0.32 | -1.57 | -1.29 | Upgrade |
Cash Interest Paid | 0.01 | - | - | - | - | 0.54 | Upgrade |
Cash Income Tax Paid | - | - | - | - | -0.01 | -0.21 | Upgrade |
Levered Free Cash Flow | -8.5 | -12.32 | -9.41 | -19.78 | -11.42 | -26.8 | Upgrade |
Unlevered Free Cash Flow | -8.49 | -12.32 | -9.41 | -19.78 | -11.42 | -26.47 | Upgrade |
Change in Working Capital | -5.19 | -2.36 | 1.92 | 31.32 | -45.45 | 0.9 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.